@article{524dc64138224e1da5046395efe60a7b,
title = "The EA2108 Clinical Trial and Real-World Data: A Cautionary Tale in Stage IV Breast Cancer",
author = "Boughey, {Judy C.} and Blair, {Sarah L.} and Subhedar, {Preeti D.} and Edge, {Stephen B.} and White, {Julia R.} and Hunt, {Kelly K.}",
note = "Funding Information: Kelly K. Hunt is a member of the Medical Advisory Board for Armada Health and AstraZeneca, and has received research funding, paid to her institution, from Cairn Surgical, Eli Lilly & Co., and Lumicell. Judy C. Boughey has received research funding from Cairns Surgical, PER, PeerView and Up-to-Date and research funding paid to her institution from Eli Lilly & Co. Sarah L. Blair, Preeti D. Subhedar, Stephen B. Edge, and Julia White have no disclosures to declare. ",
year = "2022",
month = aug,
doi = "10.1245/s10434-022-11899-1",
language = "English (US)",
volume = "29",
pages = "4663--4666",
journal = "Annals of surgical oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "8",
}